Who are we, where did we come from, why are we here?
Deep Science Ventures is a venture builder focused on rapidly creating enormous impact via the hard sciences.
Why we started DSV
Deep Science Ventures evolved out of 5 years of working with academics to shape technology to fit the market at Imperial Innovations (Imperial College's commercialisation and investment partner).

We have had the pleasure of working with teams across scientific domains from biochemistry to nano-tech and helped to start new ventures from agriculture and healthcare to new forms of solid state storage.

During the last couple of years 3 of those companies have already exited, including one to Google, whilst over 75% are continuing to grow. It's been an incredible journey, but we think there's a much bigger challenge.

Given how many people want to drive change in the world the collisions between the required deep scientific and commercial expertise are surprisingly rare. This is what we set about to change.

We've left Imperial to start DSV in January and are already seeing some incredibly high-potential ventures being built by the first batch of Founders. Join us to turn your knowledge into global impact.
Our Team
Mario Branciforti
AI, semiconductors, heavy engineering
Mario is a Principal on the investment team at Imperial Innovations where he focuses on SaaS, machine intelligence and cybersecurity, working with, Telectic and Garrison Technology among others. Previously lead strategy at NXP Semiconductors through to IPO in 2010, and, formerly MessageLabs, acquired in 2008.
Inmaculada Martinez
Data & behaviour

Originally a pioneer in WAP technology she has founded and sold several businesses all with a common theme of data and behavioral modeling. Inma was a partner at Opus Corporate Finance, is a Catalyst Member of UKTI and advises on deriving value from data in across huge number of industries for companies including IBM, HP, P&G, Unilever, IDEO, Blackrock, Sony and many others.
Jason C. Foster
Healthcare and pharma

Senior healthcare advisor specialising in marketing and operations. Previously at Reckitt Benckiser leading the growth of the global pharma business to $1.1B in revenue and a £2B LSE listing.
Dr Jonathan Crouch (MBA)
Agritech and bioeconomy
Over 20 years experience managing the scale up of business across agriculture, sustainability and healthcare in Europe, Africa, Asia and Latin America. He also built out the $60m CDC investment vehicle. Jonathan originally comes from a research background and has expertise across breeding, genetics, antibiotics, nutrition and computational modeling.
Dr Mark Hammond
Background in Neuropharmacology and AI before moving on to spend 8 years working with academics to build early stage high-tech companies (from computing to chemistry including 3 big-name exits) both at a clean-tech focused investment boutique and Imperial College's commercialisation arm Imperial Innovations.
Dominic Falcão
Previously 3 years building Imperial College's start-up community from zero to 3000 scientists, founded a social enterprise consultancy and worked in marketing at several digital start-ups.
Santa Astratova
Ecosystem Development Manager
Previously business mentor at Australia's leading business incubator, Cicada Innovations. Worked with over 70 advanced tech start-ups in areas of customer development, capital raising and business growth. Managed a med-tech commercialisation training program helping 9 companies raise over $13M in private and public investment over two years.
Made on